Healthpeak Properties Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of prem...
Latest News
4 days ago · zacks.com
What's in the Cards for Healthpeak Properties This Earnings Season?DOC is set to report Q3 earnings, with revenue growth expected to offset FFOA declines amid strong senior housing demand and lab market challenges.
21 days ago · seekingalpha.com
Healthpeak Properties: High Yield, Strong Balance Sheet, And Upside PotentialHealthpeak Properties offers a compelling 6.5% monthly dividend yield, supported by a BBB+ balance sheet and well-covered payout ratio. DOC trades at 10.65x forward FFO, well below its historical P/FFO of 14.0, presenting an attractive entry point after a recent dip. Outpatient medical and senior housing segments deliver steady results, while life science occupancy shows early signs of recovery amid sector headwinds.
26 days ago · 247wallst.com
Healthpeak Properties: Can This Healthcare REIT Keep Funding Its DividendHealthpeak's 6.
1 month ago · businesswire.com
Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and WebcastDENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 2026 financial results after the close of trading on the New York Stock Exchange on Monday, November 2, 2026. Healthpeak will host a conference call and webcast on Tuesday, November 3, 2026, at 10:00 a.m. Eastern Time to review its financial performance and operating results. The conference call can.
1 month ago · businesswire.com
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on October 1, 2026, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the fourth quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below.
2 months ago · seekingalpha.com
Healthpeak Properties: Buy Reaffirmed As Outpatient And Senior Portfolio Shows Proven PerformanceHealthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro environment, dividend coverage and high yield, an investment-grade rating, and leasing growth in Q2. Selective diversification is spread across outpatient, lab, and senior housing across a geographically diverse scale.
2 months ago · zacks.com
Why Is Healthpeak (DOC) Down 3.5% Since Last Earnings Report?Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?
2 months ago · globenewswire.com
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor AccessSAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated real estate investment trust (REIT) and S&P 500 company.
3 months ago · zacks.com
Is the Options Market Predicting a Spike in Healthpeak Properties Stock?Investors need to pay close attention to DOC stock based on the movements in the options market lately.
3 months ago · seekingalpha.com
Healthpeak Properties: The Market Still Underestimates Its Recovery PotentialHealthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoing portfolio pivot despite macro headwinds. DOC delivered a robust Q2, beating FFO and revenue estimates, increasing guidance, and executing $1 billion in asset sales to strengthen liquidity. Valuation remains compelling, with intrinsic value estimated above current levels even under conservative estimates, supported by conservative AFFO growth and a high discount rate.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove DOC